Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Four Doses of Ayahuasca or Esketamine in Major Depressive Disorder: a Double-blind Randomized Trial

NCT07212946 is registered in ClinicalTrials.gov with University of Sao Paulo as lead sponsor.

NCT NCT07212946
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07212946 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Four Doses of Ayahuasca or Esketamine in Major Depressive Disorder: a Double-blind Randomized Trial
Lead sponsor
University of Sao Paulo
Phase
Phase 2
Overall status
Completed
Start date
October 30, 2022
Completion date
October 1, 2025
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

major depression severe